A Portion-controlled Diet Will Prevent Weight Gain in Diabetics Treated With ACTOS

Completed · Phase 4

Conditions studied: Diabetes Mellitus

In brief

We hypothesized that a portion controlled diet would prevent the weight gain associated with the use of a peroxisome profliferator-activated receptor-gamma (PPAR-g). This is a 4 months randomized clinical trial in type 2 diabetics who are treated with pioglitazone and a standard diet, pioglitazone and a portion-controlled diet and metformin with a standard diet.

Key facts

Study ID

NCT00219440

Run by

Pennington Biomedical Research Center

People needed

60

Starts

2003-02-01

Expected to finish

2006-12-01

Last updated by the study team

2016-01-25

Who can join

Age: 35 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Men and women age 35 to 75 who have type 2 diabetes mellitus

You may not qualify if…

• Individuals with co-existing other diseases

Where it is running

• Pennington Center — Baton Rouge, Louisiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.